Veracyte Inc (VCYT)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SERVICES
SIC:
SERVICES-MEDICAL LABORATORIES
CEO:
Bonnie H. Anderson
Employees:
270
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA 94080
(650) 243-6300

Veracyte, Inc. is a molecular diagnostics company which uses novel genomics to resolve the critical healthcare problem of diagnostic ambiguity. The company discovers, develops and commercializes molecular diagnostic solutions that enable physicians to make more informed treatment decisions early. Veracyte was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.

Data derived from most recent annual or quarterly report
Market Cap 1.495 Billion Shares Outstanding71.218 Million Avg 30-day Volume 1.146 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.79
Price to Revenue7.8366 Debt to Equity0.0035 EBITDA-27.635 Million
Price to Book Value1.8096 Operating Margin-20.6453 Enterprise Value1.804 Billion
Current Ratio3.813 EPS Growth0.398 Quick Ratio3.295
1 Yr BETA 2.2594 52-week High/Low 54.13 / 14.85 Profit Margin-19.1154
Operating Cash Flow Growth100.1512 Altman Z-Score13.1352 Free Cash Flow to Firm -304.554 Million
Earnings Report2022-07-28
View SEC Filings from VCYT instead.

View recent insider trading info

Funds Holding VCYT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VCYT BETA

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-06-16:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-05-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-02-28:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-02-22:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-01-11:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2021-11-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-08-04:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-08-03:
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.02: Unregistered Sales of Equity Securities
  • 8-K: filed on 2021-07-29:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-07-16:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    60 Thousand total shares from 1 transactions

    Open Market Sells (S)

    23.7 Thousand total shares from 2 transactions

    Exercise Derivative Conversion (M)

    15 Thousand total shares from 1 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    JONES EVAN/ FA

    • Director
    128,104 2022-06-16 2

    BISHOP JOHN L

    • Director
    23,451 2022-06-16 1

    EASTHAM KARIN

    • Director
    23,451 2022-06-16 4

    EPSTEIN ROBERT S

    • Director
    23,451 2022-06-16 1

    BHANJI MUNA

    • Director
    26,272 2022-06-16 1

    HOLSTEIN JENS

    • Director
    16,731 2022-06-14 1

    STAPLEY MARC CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    159,761 2022-06-10 3

    GORDON KEVIN K

    • Director
    8,720 2022-06-08 1

    ANDERSON BONNIE H EXECUTIVE CHAIRWOMAN

    • Officer
    • Director
    301,388 2022-06-02 9

    KENNEDY GIULIA C CHIEF SCIENTIFIC & MED OFFICER

    • Officer
    60,353 2022-06-02 9

    NOVA TINA SUSAN PRESIDENT, CLIA U.S.

    • Officer
    180,031 2022-03-03 3

    CHAMBERS REBECCA CHIEF FINANCIAL OFFICER

    • Officer
    92,501 2022-03-03 3

    WYGANT JONATHAN VP, CHIEF ACCOUNTING OFFICER

    • Officer
    12,000 2022-03-01 1

    MCGUIRE ANNIE SVP, GENERAL COUNSEL

    • Officer
    0 2022-02-28 2

    ALLEY BEVERLY JANE VP, CORPORATE CONTROLLER

    • Officer
    13,000 2021-05-17 0

    KENNEDY KEITH COO / CFO

    • Officer
    116,858 2021-03-02 0

    HO MARK

    • PRINCIPAL ACCOUNTING OFFICER
    71,728 2021-03-02 0

    ERLINGER III JAMES H

    • EVP, GENERAL COUNSEL
    22,500 2021-02-26 0

    HANNA JOHN WALTER JR CHIEF COMMERCIAL OFFICER

    • Officer
    73,844 2020-12-02 0

    COHEN FRED E

    • Director
    10,000 2020-10-19 0

    HALL CHRISTOPHER M PRESIDENT AND COO

    • Officer
    28,258 2019-06-03 0

    TREU JESSE I

    • Director
    1,234,930 2019-02-28 0

    KLEINER PERKINS CAUFIELD & BYERS XII, LLC

    KPCB XII FOUNDERS FUND, LLC

    KPCB XII ASSOCIATES, LLC

    • 10% Owner
    No longer subject to file 2017-03-10 0

    BROOKS JULIE EVP, GEN COUNSEL AND SECRETARY

    • Officer
    4,162 2017-03-03 0

    ATWOOD BRIAN G

    • Director
    • 10% Owner
    0 2016-06-20 0

    GUYER SHELLY D CHIEF FINANCIAL OFFICER

    • Officer
    0 2016-03-01 0

    POWELL DUNCAN THOMAS PRINCIPAL ACCOUNTING OFFICER

    • Officer
    0 2015-03-02 0

    DOMAIN PARTNERS VIII, L.P.

    BLAIR JAMES C

    DOVEY BRIAN H

    TREU JESSE I

    SCHOEMAKER KATHLEEN K

    VITULLO NICOLE

    HALAK BRIAN K

    • Director
    • 10% Owner
    2,763,294 2014-09-10 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    HOLSTEIN JENS - Director

    2022-06-16 20:04:27 -0400 2022-06-16 A 14,731 a 16,731 direct 2.8235 23.4706 33.7647 5 0.0 1

    JONES EVAN/ FA - Director

    2022-06-16 20:06:33 -0400 2022-06-16 A 14,731 a 58,451 direct 2.8235 23.4706 33.7647 5 0.0 1

    EPSTEIN ROBERT S - Director

    2022-06-16 20:12:55 -0400 2022-06-16 A 14,731 a 23,451 direct 2.8235 23.4706 33.7647 5 0.0 1

    EASTHAM KARIN - Director

    2022-06-16 20:12:36 -0400 2022-06-16 A 14,731 a 23,451 direct 2.8235 23.4706 33.7647 5 0.0 1

    BHANJI MUNA - Director

    2022-06-16 20:12:18 -0400 2022-06-16 A 14,731 a 26,272 direct 2.8235 23.4706 33.7647 5 0.0 1

    BISHOP JOHN L - Director

    2022-06-16 20:11:56 -0400 2022-06-16 A 14,731 a 23,451 direct 2.8235 23.4706 33.7647 5 0.0 1

    HOLSTEIN JENS - Director

    2022-06-16 20:04:27 -0400 2022-06-14 S 8,720 $16.27 d 2,000 direct 2.8235 23.4706 33.7647 5 0.0 1

    STAPLEY MARC - Director - Officer CHIEF EXECUTIVE OFFICER

    2022-06-13 08:19:22 -0400 2022-06-10 P 60,000 $16.33 a 159,761 direct 1.5038 9.5238 12.4687 3 0.0 1

    GORDON KEVIN K - Director

    2022-06-10 16:45:40 -0400 2022-06-08 M 15,000 $7.39 a 23,720 direct 1.5038 9.5238 12.4687 3 0.0 1

    GORDON KEVIN K - Director

    2022-06-10 16:45:40 -0400 2022-06-08 S 15,000 $18.50 d 8,720 direct 1.5038 9.5238 12.4687 3 0.0 1

    GORDON KEVIN K - Director

    2022-06-10 16:45:40 -0400 2022-06-08 M 15,000 d 0 direct

    KENNEDY GIULIA C - Officer CHIEF SCIENTIFIC & MED OFFICER

    2022-06-06 16:22:07 -0400 2022-06-02 F 1,008 $18.23 d 60,353 direct 4.1433 -9.2945 4.1433 2 -10.6383 5

    STAPLEY MARC - Director - Officer CHIEF EXECUTIVE OFFICER

    2022-06-06 16:24:53 -0400 2022-06-02 F 4,047 $18.23 d 99,761 direct 4.1433 -9.2945 4.1433 2 -10.6383 5

    ANDERSON BONNIE H - Director - Officer EXECUTIVE CHAIRWOMAN

    2022-06-06 16:27:49 -0400 2022-06-02 F 2,042 $18.23 d 67,045 direct 4.1433 -9.2945 4.1433 2 -10.6383 5

    ANDERSON BONNIE H - Director - Officer EXECUTIVE CHAIRWOMAN

    2022-05-03 17:43:44 -0400 2022-05-01 F 736 $20.47 d 85,952 direct -15.3229 -31.1804 -24.4098 0.0 1 -31.1804 6

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    VERACYTE INC VCYT 2022-06-28 22:15:04 UTC 1.1575 0.4125 700000
    VERACYTE INC VCYT 2022-06-28 21:45:03 UTC 1.156 0.414 700000
    VERACYTE INC VCYT 2022-06-28 21:15:03 UTC 1.156 0.414 700000
    VERACYTE INC VCYT 2022-06-28 20:45:03 UTC 1.156 0.414 700000
    VERACYTE INC VCYT 2022-06-28 20:15:04 UTC 1.156 0.414 700000
    VERACYTE INC VCYT 2022-06-28 19:45:03 UTC 1.156 0.414 700000
    VERACYTE INC VCYT 2022-06-28 19:15:03 UTC 1.156 0.414 700000
    VERACYTE INC VCYT 2022-06-28 18:45:03 UTC 1.1558 0.4142 700000
    VERACYTE INC VCYT 2022-06-28 18:15:04 UTC 1.1558 0.4142 700000
    VERACYTE INC VCYT 2022-06-28 17:45:03 UTC 1.1558 0.4142 700000
    VERACYTE INC VCYT 2022-06-28 17:15:03 UTC 1.1558 0.4142 700000
    VERACYTE INC VCYT 2022-06-28 16:45:06 UTC 1.1524 0.4176 700000
    VERACYTE INC VCYT 2022-06-28 16:15:03 UTC 1.1524 0.4176 700000
    VERACYTE INC VCYT 2022-06-28 15:45:03 UTC 1.1524 0.4176 700000
    VERACYTE INC VCYT 2022-06-28 15:15:03 UTC 1.1524 0.4176 700000
    VERACYTE INC VCYT 2022-06-28 14:45:03 UTC 1.1524 0.4176 700000
    VERACYTE INC VCYT 2022-06-28 14:15:04 UTC 1.1524 0.4176 700000
    VERACYTE INC VCYT 2022-06-28 13:45:03 UTC 1.1524 0.4176 700000
    VERACYTE INC VCYT 2022-06-28 13:15:03 UTC 1.1524 0.4176 700000
    VERACYTE INC VCYT 2022-06-28 12:45:03 UTC 1.1524 0.4176 700000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    FundVantage Trust- Gotham Index Plus All-Cap Fund VCYT -27.0 shares, $-656.37 2020-03-31 N-PORT
    RUSSELL INVESTMENT CO- U.S. Dynamic Equity Fund VCYT -4094.0 shares, $-232129.8 2021-01-31 N-PORT
    RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund VCYT -18759.0 shares, $-570461.19 2022-01-31 N-PORT
    RUSSELL INVESTMENT CO- Sustainable Equity Fund VCYT -8785.0 shares, $-267151.85 2022-01-31 N-PORT
    RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund VCYT -6202.0 shares, $-170989.14 2022-03-31 N-PORT
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund VCYT -3700.0 shares, $-102009.0 2022-03-31 N-PORT

    Elevate your investments